Salta al contenuto principale

oncostatin M receptor

L OSMR gene provides instructions for making a protein called oncostatin M receptor beta subunit (OSMRβ). This protein is one piece (subunit) of both the oncostatin M (OSM) receptor type II and the interleukin-31 (IL-31) receptor. These receptors are embedded in the cell membrane of many types of cells throughout the body. Each attaches to a particular protein, fitting together like a lock and its key. This attachment triggers a series of chemical signals inside the cell that directs certain cell functions.

Scelte video per Genes
Video library

Normal function

L OSMR gene provides instructions for making a protein called oncostatin M receptor beta subunit (OSMRβ). This protein is one piece (subunit) of both the oncostatin M (OSM) receptor type II and the interleukin-31 (IL-31) receptor. These receptors are embedded in the cell membrane of many types of cells throughout the body. Each attaches to a particular protein, fitting together like a lock and its key. This attachment triggers a series of chemical signals inside the cell that directs certain cell functions.

OSM receptor type II interacts with a protein called oncostatin M (OSM). Signaling triggered by OSM was first recognized to block the growth of cancerous cells and appears to play a role in many other body processes, including the development of blood cells, the maturation of cells to become certain cell types, and an immune system response called inflammation. The signaling may also block the self-destruction (apoptosis) of cells.

The IL-31 receptor interacts with a protein called IL-31. Signaling triggered by IL-31 is involved in inflammation and stimulating itching (pruritus), although its role is not completely understood.

Conditions referring to this gene or chromosome

Altri nomi

IL-31 receptor subunit beta

IL-31R subunit beta

IL-31R-beta

IL-31RB

interleukin-31 receptor subunit beta

oncostatin-M specific receptor beta subunit

OSMRB

PLCA1

Related patient information and medicines

Nefropatia da IgA

Patient information leaflet

Nefropatia da IgA

Nefropatia da IgA is a condition in which a protein causes damage to the kidneys. The medicines used for blood pressure control with IgA nephropathy are angiotensin-converting enzyme (ACE) inhibitors ACE inhibitors or angiotensin receptor blockers (ARBs) - for example, losartan Losartan - an angiotensin receptor blocker. Even if you don't have high.

Innesto di bypass coronarico

Patient information leaflet

Innesto di bypass coronarico

C oronary artery bypass grafting (CABG) is a type of heart surgery to treat coronary artery disease. The standard surgery requires open heart surgery and stopping of the heart temporarily. Coronary artery bypass grafting, called CABG for short (pronounced 'cabbage'), is a heart operation. It is also called coronary artery bypass surgery. A CABG is.

Cardiomiopatia dilatativa

Patient information leaflet

Cardiomiopatia dilatativa

Cardiomiopatia dilatativa is a condition where the heart muscle becomes stretched and thin. The heart becomes enlarged (dilates) and pumps blood less well. Symptoms vary according to severity and the treatment depends on the type of symptoms and whether any complications develop. Some forms of dilated cardiomyopathy run in families. A normal heart.

Ipercolesterolemia familiare

Patient information leaflet

Ipercolesterolemia familiare

Ipercolesterolemia familiare is inherited colesterolo alto. The usual medicine to start with is a statin Statins e altri lipid-lowering medicines. ...mmon statin used is called atorvastatinDr Krishna Vakharia , 13th September 2024 The National Institute for Health and Care Excellence (NICE) is recommending evinacumab alongside diet and other.

Diabete e malattia

Patient information leaflet

Diabete e malattia

It is very important to know how to cope with illness se hai diabete or know or care for somebody with diabetes. Further information on managing diabetes during a period of illness è available on the Diabete UK website (see Further Reading below for the link). On angiotensin-converting enzyme (ACE) inhibitors ACE inhibitors , angiotensin.

Miastenia grave

Patient information leaflet

Miastenia grave

Myasthenia gravis (MG) is a condition where muscles become easily tired and weak. It is due to a problem with how the nerves stimulate the muscles to tighten (contract). The muscles around the eyes are commonly affected first. What causes myasthenia gravis. Myasthenia gravis is an autoimmune disease. This means that the immune system The immune.

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
  • 18 Ago 2020 | Ultima versione
  • 1 Oct 2016 | Pubblicato originariamente

Partecipa alla conversazione

Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.

Avvertenza: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmacia online, trattamenti e servizi sanitari

Accesso semplice a trattamenti affidabili e servizi sanitari online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Iscriviti alla newsletter di Patient

La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.

Per favore, inserisci un indirizzo email valido

Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.